Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak

Patricia Pérez-Galán, Gaël Roué, Neus Villamor, Elias Campo, Dolors Colomer

Blood (2007) 109 (10): 4441–4449.

https://doi.org/10.1182/blood-2006-07-034173

Published: 2007

Journal Articles

Selective Inhibition of I kappaB Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing c-FLIP Level.

Gaël Roué, PhD, Patricia Pérez-Galán, PhD, Mónica López-Guerra, BS, Neus Villamor, MD, PhD, Elias Campo, MD, PhD, Dolors Colomer, PhD

Blood (2006) 108 (11): 258.

https://doi.org/10.1182/blood.V108.11.258.258

Published: 2006

Journal Articles

Activity of Bendamustine (TREANDA™) in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells with Alterations in DNA Damage Response Pathway.

Gaël Roué, PhD, Mónica López-Guerra, BS, Pierre Milpied, BS, Patricia Pérez-Galán, PhD, Neus Villamor, MD,PhD, Elias Campo, MD,PhD, Dolors Colomer, PhD

Blood (2006) 108 (11): 2510.

https://doi.org/10.1182/blood.V108.11.2510.2510

Published: 2006

Journal Articles

The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

Patricia Pérez-Galán, Gaël Roué, Neus Villamor, Emili Montserrat, Elias Campo, Dolors Colomer

Blood (2006) 107 (1): 257–264.

https://doi.org/10.1182/blood-2005-05-2091

Published: 2006

Journal Articles

Polymorphisms in the Promoter Region of the Mcl-1 Gene Are Associated with Ex Vivo Cytotoxicity but Not with Response to Treatment in Advanced Chronic Lymphocytic Leukemia (CLL).

Neus Villamor, Silvia Marce, Francesc Bosch, Anna Ferrer, Patricia Pérez-Galán, Armando López-Guillermo, Eva Giné, Elías Campo, Emili Montserrat, Dolors Colomer

Blood (2005) 106 (11): 4991.

https://doi.org/10.1182/blood.V106.11.4991.4991

Published: 2005

NARROW

The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak

Selective Inhibition of I kappaB Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing c-FLIP Level.

Activity of Bendamustine (TREANDA™) in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells with Alterations in DNA Damage Response Pathway.

The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

Polymorphisms in the Promoter Region of the Mcl-1 Gene Are Associated with Ex Vivo Cytotoxicity but Not with Response to Treatment in Advanced Chronic Lymphocytic Leukemia (CLL).

Email alerts

ASH Publications

American Society of Hematology

The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak

Selective Inhibition of I kappaB Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing c-FLIP Level.

Activity of Bendamustine (TREANDA™) in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells with Alterations in DNA Damage Response Pathway.

The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

Polymorphisms in the Promoter Region of the Mcl-1 Gene Are Associated with Ex Vivo Cytotoxicity but Not with Response to Treatment in Advanced Chronic Lymphocytic Leukemia (CLL).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only